Alnylam Pharmaceuticals, Inc. vs Pfizer, Inc. — Stock Comparison
Alnylam Pharmaceuticals, Inc. (ALNY) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Alnylam Pharmaceuticals, Inc. scores ahead of Pfizer, Inc. on Q·Score (7.8 vs 6.4 out of 10), led by Growth (8 vs 5.1) and Sentiment (7.5 vs 5.3). Pfizer, Inc. scores higher on Health, reflecting stronger balance sheet strength. Analyst consensus targets imply greater upside for ALNY (+56.9%) than for PFE (+15.8%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Consensus analyst target of $436.32 is 57% above current price.
Forward P/E of 8.9× is low relative to sector peers.
⚠ earnings contracting 10% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
ALNY vs PFE: which stock scores better overall?
Based on Q·Score, Alnylam Pharmaceuticals, Inc. (ALNY) scores 7.8/10 versus Pfizer, Inc. (PFE) at 6.4/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: ALNY or PFE?
Alnylam Pharmaceuticals, Inc. (ALNY) scores higher on Growth (8/10 vs 5.1/10). Alnylam Pharmaceuticals, Inc. reports revenue growth (96.4% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is ALNY or PFE more attractively valued?
Alnylam Pharmaceuticals, Inc. (ALNY) scores higher on Valuation (9.1/10 vs 7.7/10). ALNY trades at 20.2× P/E versus PFE at 8.9×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about ALNY vs PFE?
There are 25 analysts covering ALNY with a consensus price target of $436.32, and 27 analysts covering PFE with a consensus target of $29.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: ALNY or PFE?
Alnylam Pharmaceuticals, Inc. (ALNY) scores higher on Quality (8.2/10 vs 6.4/10). Net profit margin: ALNY at 12.6%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: ALNY or PFE?
Pfizer, Inc. (PFE) scores higher on Financial Health (7/10 vs 6.2/10). Market beta: ALNY at 0.27, PFE at 0.29. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of ALNY and PFE?
Alnylam Pharmaceuticals, Inc. (ALNY) has a market capitalisation of $37.1B, while Pfizer, Inc. (PFE) has a market cap of $143.7B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do ALNY or PFE pay dividends?
ALNY does not currently pay a dividend, while PFE pays a dividend yield of 6.61%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →